-
1 month ago | 
lexology.com | James Ravitz |Paul S. Gadiock |Marshall Jackson |Patrick Zanayed |Lisa S. Mazur |Jae Lee
On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 (GLP-1) medication, marking the shortage as “resolved” for all presentations of the drug.
-
Nov 19, 2024 | 
mondaq.com | Lisa S. Mazur |Dale Van Demark |Amanda Enyeart |Marshall Jackson
The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to
prescribe controlled substances via telemedicine without first
performing an in-person visit. The flexibilities were initially
provided during the COVID-19 public health emergency (PHE) and were
scheduled to expire on December 31, 2024. This extension extends
the flexibilities through December 31, 2025.
-
Oct 28, 2024 | 
mondaq.com | Patrick Zanayed |Lisa S. Mazur |Marshall Jackson |Amanda Enyeart
MW
McDermott Will & Emery
More
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 1,100 lawyers across several office locations worldwide, our team works seamlessly across practices, industries and geographies to deliver highly effective solutions that propel success.
-
Oct 9, 2024 | 
lexology.com | James Ravitz |Paul S. Gadiock |Marshall Jackson |Lisa S. Mazur |Patrick Zanayed |Paul Hughes | +1 more
On October 3, 2024, the US Food and Drug Administration (FDA) revised its shortage categorization of tirzepatide, a glucagon-like peptide 1 (GLP-1) medication, marking the shortage as “resolved” for all presentations of the drug. An end to the shortage has important implications for industry stakeholders at various points in the medication’s supply chain. Compounding pharmacies and providers should be aware of the impact this change in shortage status has on their operations.
-
Sep 30, 2024 | 
mondaq.com | Caroline Reignley |Marshall Jackson |James Cannatti III |Lisa S. Mazur
On September 24, 2024, the Office of Inspector General (OIG) at
the US Department of Health and Human Services issued a report
recommending additional oversight of remote physiologic monitoring
(RPM) services furnished to Medicare beneficiaries. The full report
is available here.
Many of the issues highlighted by OIG are inherent to the
current RPM codes established by the American Medical Association
(AMA) but may not actually be problematic.
-
Aug 28, 2024 | 
mondaq.com | Lisa S. Mazur |Patrick Zanayed |Nathan Gray |Travis Jackson
In California, pending Assembly Bill 3129 (the Act) could
severely limit the ability of digital health companies to grow and
operate in the state by prohibiting arrangements between physician,
psychiatric, and dental practices and any entity that furnishes
business or management services to providers that accept
investments from private equity groups and hedge funds.
-
May 31, 2023 | 
mondaq.com | Lisa S. Mazur
In this session, McDermott Will & Emery Partner Lisa Mazur
moderated a panel that explored how digital health tools can
support financial and clinical success under value-based care
arrangements. Panelists also looked at how digital health companies
can successfully demonstrate value within the value-based care
framework and make themselves attractive partners to value-based
care companies.
-
May 12, 2023 | 
lexology.com | Amanda Enyeart |Marshall Jackson |Tony Maida |Lisa S. Mazur |Dexter Golinghorst
On April 20, 2023, the United States Department of Health and Human Services Office of the Inspector General (HHS OIG) released a new toolkit designed to help analyze telehealth claims to assess federal healthcare program integrity risks. The toolkit is OIG’s latest action in its continued focus on telehealth services that OIG considers to be high risk.
-
Mar 21, 2023 | 
lexology.com | Amanda Enyeart |Grayson Dimick |Marshall Jackson |Lisa S. Mazur |Stephen W. Bernstein
Register now for your free, tailored, daily legal newsfeed service. Questions? Please contact RegisterTo view this article you need a PDF viewer such as Adobe Reader. If you can't read this PDF, you can view its text here. Go back to the PDF. USAMarch 21 2023Digital health is one of the fast-growing segments of he healthcare market, with patients, clinicians andregulators increasingly aligned behind theopportunities that digitization presents.
-
Feb 28, 2023 | 
lexology.com | Amanda Enyeart |Grayson Dimick |Marshall Jackson |Lisa S. Mazur |Stephen W. Bernstein
OVERVIEWDigital health is one of the fast-growing segments ofthe healthcare market, with patients, clinicians andregulators increasingly aligned behind theopportunities that digitization presents. Over the last three years, patients and clinicians alikehave embraced digitally delivered care and telehealth-related flexibilities.
